Physician profile
Andy C Huang
NPI 1265569040
$3,765.39
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,450 · 2020: $615 · 2021: $1,069 · 2022: $632.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,799.18 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $605.14 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $383.94 | 2020-2021 | |
| Optos, INC. | $361.03 | 2019-2021 | |
| Alcon Vision LLC | $215.47 | 2022 | |
| Novartis Pharmaceuticals Corporation | $113.57 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $110.18 | 2019 | |
| Bausch & Lomb Americas INC. | $96.52 | 2022 | |
| Abb Con-Cise Optical Group LLC | $35.49 | 2022 | |
| Visioneering Technologies, INC. | $25.47 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.